Apyx Medical
APYX
62 hedge funds and large institutions have $45.7M invested in Apyx Medical in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 12 closing their positions.
3,133% more call options, than puts
Call options by funds: $97K | Put options by funds: $3K
25% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 16
0% more funds holding
Funds holding: 62 → 62 (0)
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
2.53% less ownership
Funds ownership: 52.91% → 50.38% (-2.5%)
22% less capital invested
Capital invested by funds: $58.7M → $45.7M (-$12.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$454K |
| 2 |
RA
Royce & Associates
New York
|
+$361K |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$352K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$158K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$135K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$1.83M |
| 2 |
RI
RTW Investments
New York
|
-$1.82M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$1.19M |
| 4 |
Millennium Management
New York
|
-$474K |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
-$448K |
APYX Hedge Fund Activity: Q4 2023 in Review
62 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2023, worth a combined $45.7M — down 22% from $58.7M a quarter earlier.
Fund positioning in APYX was balanced in Q4 2023: 12 funds opened new positions, 12 closed out, 20 added to existing stakes and 16 trimmed.
The largest buyer was Raymond James Financial Services Advisors, adding an estimated $454K. The largest seller was Pura Vida Investments, cutting an estimated $1.83M.
- 62 institutional investors held Apyx Medical (APYX) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $45.7M of Apyx Medical stock for Q4 2023, down 22% quarter-over-quarter.
- 12 funds opened new Apyx Medical positions in Q4 2023 and 12 closed out, a net change of 0 holders.
- The largest Apyx Medical buyer in Q4 2023 was Raymond James Financial Services Advisors, an estimated $454K added.
- The largest Apyx Medical seller in Q4 2023 was Pura Vida Investments, an estimated $1.83M sold.
Based on aggregated 13F filings for Q4 2023.